• 본문 바로가기(Skip Contents)
ENGLISH
  • KOREAN
  • HOME

corestem

  • ABOUT US
    • Overview
    • History
    • Manufacturing facility
    • Our Company
  • PRODUCT
    • ALS (NeuroNata-R®)
    • Lou Gehrig's disease
  • PIPELINE
    • Pipeline
    • SLE
    • CA
  • R&D
    • Stem Cell Therapy
  • IR
    • Stock Information
    • Disclosures
    • Finances
    • Announcement of Settlement
    • IR Inquiry
  • PR
    • Press Report
    • Notice
    • Media
    • Online Inquiry

전체메뉴

전체메뉴

  • ABOUT US

    Overview History Manufacturing facility Our Company
  • PRODUCT

    ALS (NeuroNata-R®) Lou Gehrig's disease
  • PIPELINE

    Pipeline SLE CA
  • R&D

    Stem Cell Therapy
  • IR

    Stock Information Disclosures Finances Announcement of Settlement IR Inquiry
  • PR

    Press Report Notice Media Online Inquiry
  • HOME
ENGLISH
  • KOREAN
  • ABOUT US
    • Overview
    • History
    • Manufacturing facility
    • Our Company
  • PRODUCT
    • ALS (NeuroNata-R®)
    • Lou Gehrig's disease
  • PIPELINE
    • Pipeline
    • Target Disease
    • Lupus
  • R&D
    • Stem Cell Therapy
  • IR
    • Stock Information
    • Disclosures
    • Finances
    • Announcement of Settlement
    • IR Inquiry
  • PR
    • Press Report
    • Notice
    • Media
    • Online Inquiry

PR

Corestem is a biopharmaceutical company that researches and commercializes stem cell technology.

  • Press Report
  • Notice
  • Media
  • Online Inquiry
  • Press Report
  • Notice
  • Media
  • Online Inquiry

언론보도

  • 2020.11.19
    [한경 팩트체크]코아스템, 루게릭병 줄기세포치료제 '퍼..

    [한경 팩트체크]코아스템, 루게릭병 줄기세포치료제 '퍼스트무버' 등극줄기세포치료제 기업 코아스템의 주가가 1..

  • 2020.11.11
    코아스템 "뉴로나타-알주, 美 FDA로부터..

    코아스템 "뉴로나타-알주, 美 FDA로부터 RMAT 미지정"김경택 기자입력 : 2020.1..

  • 2020.10.29
    [기업탐탐] 줄기세포 치료제로 미국 공략, 코아스템

    [앵커멘트] 기자들이 직접 기업탐방을 다녀오고 그 현장을 생생히 전해드리는 기업탐탐 시간입니다. 오늘은..

  • 2020.10.27
    코아스템, '바이오 유럽 2020' 참가…기술 수출..

    코아스템, '바이오 유럽 2020' 참가…기술 수출 계약 논의코아스템이 오는 26~29일 온라인으로 개최되는..

  • 2020.10.22
    코아스템, 다계통 위축증 치료제 임상 1상 완료

    코아스템, 다계통 위축증 치료제 임상 1상 완료안전성 확보 이후 효력연구 집중코아스템은 다계통 위축증(Mu..

  • 2020.09.14
    코아스템, 루게릭병 치료제 美 첨단재생의약치료제 신청

    코아스템, 루게릭병 치료제 美 첨단재생의약치료제 신청입력 2020-09-14 10:32수정 2020-09-..

  • 6
  • 7
  • 8
  • 9
  • 10
  • ABOUT US
    Overview History Manufacturing facility Our Company
  • PRODUCT
    ALS (NeuroNata-R®) Lou Gehrig's disease
  • PIPELINE
    Pipeline Target Disease Lupus
  • R&D
    Stem Cell Therapy
  • IR
    Stock Information Disclosures Finances Announcement of Settlement IR relations
  • PR
    Press Report Notice Media Online Inquiry

Contact Information
  • 24, Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea
  • Gen (02) 497-3711
  • IR DID 070-4706-3546
  • FAX (02) 6349-8666
  • E-MAIL corestem@corestem.com
Copyright 2018 CORESTEM, Inc All right reserved.